MDWD micro cap coming out of a nice base - phase 3 trial results and earnings on the horizon as potential catalysts here
Low float, recent $5 price target. Waiting on FDA acceptance
Company Information MediWound Ltd. is a biopharmaceutical company. The Company focuses on developing, manufacturing and commercializing therapeutics products in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders and other indications. The Company's product, NexoBrid, is indicated for the removal of dead or damaged...